APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rosuvastatin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Rosuvastatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025196 pages

Choose your research edition.

Industry ResearchRosuvastatin Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Rosuvastatin Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Rosuvastatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rosuvastatin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Rosuvastatin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Rosuvastatin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Rosuvastatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rosuvastatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rosuvastatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Rosuvastatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rosuvastatin include Teva Pharmaceutical Industries, Shandong Bechem Chemicals, Nanjing Frochem Tech, Lianyungang Runzhong Pharmaceutical, Jingxin Pharm, Zhejiang Hisun Pharmaceutical, Changzhou Pharmaceutical Factory, MSN Laboratories and Lunan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rosuvastatin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rosuvastatin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rosuvastatin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rosuvastatin market size, projected growth trends, production technologies, key applications, and end-use industries.

Rosuvastatin Segment by Company

Teva Pharmaceutical Industries

Shandong Bechem Chemicals

Nanjing Frochem Tech

Lianyungang Runzhong Pharmaceutical

Jingxin Pharm

Zhejiang Hisun Pharmaceutical

Changzhou Pharmaceutical Factory

MSN Laboratories

Lunan Pharmaceutical

LGM Pharma

HEC Pharm

CTX Life Sciences

Cadila Pharmaceuticals

Bal Pharma

AstraZeneca

Rosuvastatin Segment by Type

Purity 98.0%

Purity 99.0%

Other

Rosuvastatin Segment by Application

Tablet

Capsule

Others

Rosuvastatin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rosuvastatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rosuvastatin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rosuvastatin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rosuvastatin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rosuvastatin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Rosuvastatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Rosuvastatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Rosuvastatin Industry Trends Table 2. Rosuvastatin Industry Drivers Table 3. Rosuvastatin Industry Opportunities and Challenges Table 4. Rosuvastatin Industry Restraints Table 5. Global Rosuvastatin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Rosuvastatin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Rosuvastatin Sales by Manufacturers (W Tons) & (2021-2026) Table 8. Global Rosuvastatin Sales Market Share by Manufacturers Table 9. Global Rosuvastatin Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Rosuvastatin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Rosuvastatin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Rosuvastatin Manufacturers, Product Type & Application Table 13. Global Rosuvastatin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Rosuvastatin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Purity 98.0% Table 17. Major Manufacturers of Purity 99.0% Table 18. Major Manufacturers of Other Table 19. Global Rosuvastatin Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 20. Global Rosuvastatin Sales by Type (2021-2026) & (W Tons) Table 21. Global Rosuvastatin Sales by Type (2027-2032) & (W Tons) Table 22. Global Rosuvastatin Sales Market Share by Type (2021-2026) Table 23. Global Rosuvastatin Sales Market Share by Type (2027-2032) Table 24. Global Rosuvastatin Revenue by Type 2021 VS 2025 VS 2032 (W Tons) Table 25. Global Rosuvastatin Revenue by Type (2021-2026) & (W Tons) Table 26. Global Rosuvastatin Revenue by Type (2027-2032) & (W Tons) Table 27. Global Rosuvastatin Revenue Market Share by Type (2021-2026) Table 28. Global Rosuvastatin Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Tablet Table 30. Major Manufacturers of Capsule Table 31. Major Manufacturers of Others Table 32. Global Rosuvastatin Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 33. Global Rosuvastatin Sales by Application (2021-2026) & (W Tons) Table 34. Global Rosuvastatin Sales by Application (2027-2032) & (W Tons) Table 35. Global Rosuvastatin Sales Market Share by Application (2021-2026) Table 36. Global Rosuvastatin Sales Market Share by Application (2027-2032) Table 37. Global Rosuvastatin Revenue by Application 2021 VS 2025 VS 2032 (W Tons) Table 38. Global Rosuvastatin Revenue by Application (2021-2026) & (W Tons) Table 39. Global Rosuvastatin Revenue by Application (2027-2032) & (W Tons) Table 40. Global Rosuvastatin Revenue Market Share by Application (2021-2026) Table 41. Global Rosuvastatin Revenue Market Share by Application (2027-2032) Table 42. Global Rosuvastatin Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 43. Global Rosuvastatin Sales by Region (2021-2026) & (W Tons) Table 44. Global Rosuvastatin Sales Market Share by Region (2021-2026) Table 45. Global Rosuvastatin Sales Forecasted by Region (2027-2032) & (W Tons) Table 46. Global Rosuvastatin Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Rosuvastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 48. North America Rosuvastatin Sales by Country (2021-2026) & (W Tons) Table 49. North America Rosuvastatin Sales by Country (2027-2032) & (W Tons) Table 50. Europe Rosuvastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 51. Europe Rosuvastatin Sales by Country (2021-2026) & (W Tons) Table 52. Europe Rosuvastatin Sales by Country (2027-2032) & (W Tons) Table 53. Asia Pacific Rosuvastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 54. Asia Pacific Rosuvastatin Sales by Country (2021-2026) & (W Tons) Table 55. Asia Pacific Rosuvastatin Sales by Country (2027-2032) & (W Tons) Table 56. South America, Middle East and Africa Rosuvastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 57. South America, Middle East and Africa Rosuvastatin Sales by Country (2021-2026) & (W Tons) Table 58. South America, Middle East and Africa Rosuvastatin Sales by Country (2027-2032) & (W Tons) Table 59. Global Rosuvastatin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Rosuvastatin Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Rosuvastatin Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Rosuvastatin Revenue Market Share by Region (2021-2026) Table 63. Global Rosuvastatin Revenue Market Share by Region (2027-2032) Table 64. Teva Pharmaceutical Industries Company Information Table 65. Teva Pharmaceutical Industries Business Overview Table 66. Teva Pharmaceutical Industries Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Pharmaceutical Industries Rosuvastatin Product Portfolio Table 68. Teva Pharmaceutical Industries Recent Development Table 69. Shandong Bechem Chemicals Company Information Table 70. Shandong Bechem Chemicals Business Overview Table 71. Shandong Bechem Chemicals Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Shandong Bechem Chemicals Rosuvastatin Product Portfolio Table 73. Shandong Bechem Chemicals Recent Development Table 74. Nanjing Frochem Tech Company Information Table 75. Nanjing Frochem Tech Business Overview Table 76. Nanjing Frochem Tech Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Nanjing Frochem Tech Rosuvastatin Product Portfolio Table 78. Nanjing Frochem Tech Recent Development Table 79. Lianyungang Runzhong Pharmaceutical Company Information Table 80. Lianyungang Runzhong Pharmaceutical Business Overview Table 81. Lianyungang Runzhong Pharmaceutical Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Lianyungang Runzhong Pharmaceutical Rosuvastatin Product Portfolio Table 83. Lianyungang Runzhong Pharmaceutical Recent Development Table 84. Jingxin Pharm Company Information Table 85. Jingxin Pharm Business Overview Table 86. Jingxin Pharm Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Jingxin Pharm Rosuvastatin Product Portfolio Table 88. Jingxin Pharm Recent Development Table 89. Zhejiang Hisun Pharmaceutical Company Information Table 90. Zhejiang Hisun Pharmaceutical Business Overview Table 91. Zhejiang Hisun Pharmaceutical Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Zhejiang Hisun Pharmaceutical Rosuvastatin Product Portfolio Table 93. Zhejiang Hisun Pharmaceutical Recent Development Table 94. Changzhou Pharmaceutical Factory Company Information Table 95. Changzhou Pharmaceutical Factory Business Overview Table 96. Changzhou Pharmaceutical Factory Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Changzhou Pharmaceutical Factory Rosuvastatin Product Portfolio Table 98. Changzhou Pharmaceutical Factory Recent Development Table 99. MSN Laboratories Company Information Table 100. MSN Laboratories Business Overview Table 101. MSN Laboratories Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. MSN Laboratories Rosuvastatin Product Portfolio Table 103. MSN Laboratories Recent Development Table 104. Lunan Pharmaceutical Company Information Table 105. Lunan Pharmaceutical Business Overview Table 106. Lunan Pharmaceutical Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Lunan Pharmaceutical Rosuvastatin Product Portfolio Table 108. Lunan Pharmaceutical Recent Development Table 109. LGM Pharma Company Information Table 110. LGM Pharma Business Overview Table 111. LGM Pharma Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. LGM Pharma Rosuvastatin Product Portfolio Table 113. LGM Pharma Recent Development Table 114. HEC Pharm Company Information Table 115. HEC Pharm Business Overview Table 116. HEC Pharm Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. HEC Pharm Rosuvastatin Product Portfolio Table 118. HEC Pharm Recent Development Table 119. CTX Life Sciences Company Information Table 120. CTX Life Sciences Business Overview Table 121. CTX Life Sciences Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. CTX Life Sciences Rosuvastatin Product Portfolio Table 123. CTX Life Sciences Recent Development Table 124. Cadila Pharmaceuticals Company Information Table 125. Cadila Pharmaceuticals Business Overview Table 126. Cadila Pharmaceuticals Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Cadila Pharmaceuticals Rosuvastatin Product Portfolio Table 128. Cadila Pharmaceuticals Recent Development Table 129. Bal Pharma Company Information Table 130. Bal Pharma Business Overview Table 131. Bal Pharma Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Bal Pharma Rosuvastatin Product Portfolio Table 133. Bal Pharma Recent Development Table 134. AstraZeneca Company Information Table 135. AstraZeneca Business Overview Table 136. AstraZeneca Rosuvastatin Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. AstraZeneca Rosuvastatin Product Portfolio Table 138. AstraZeneca Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Rosuvastatin Distributors List Table 142. Rosuvastatin Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Rosuvastatin Product Image Figure 2. Global Rosuvastatin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rosuvastatin Market Size (2021-2032) & (US$ Million) Figure 4. Global Rosuvastatin Sales (2021-2032) & (W Tons) Figure 5. Global Rosuvastatin Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Rosuvastatin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Purity 98.0% Image Figure 9. Purity 99.0% Image Figure 10. Other Image Figure 11. Global Rosuvastatin Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 12. Global Rosuvastatin Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Rosuvastatin Sales Market Share by Type (2021-2032) Figure 14. Global Rosuvastatin Revenue by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 15. Global Rosuvastatin Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Rosuvastatin Revenue Market Share by Type (2021-2032) Figure 17. Tablet Image Figure 18. Capsule Image Figure 19. Others Image Figure 20. Global Rosuvastatin Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 21. Global Rosuvastatin Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Rosuvastatin Sales Market Share by Application (2021-2032) Figure 23. Global Rosuvastatin Revenue by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 24. Global Rosuvastatin Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Rosuvastatin Revenue Market Share by Application (2021-2032) Figure 26. North America Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 27. North America Rosuvastatin Sales Market Share by Country (2021-2032) Figure 28. U.S. Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 29. Canada Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 30. Mexico Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 31. Europe Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 32. Europe Rosuvastatin Sales Market Share by Country (2021-2032) Figure 33. Germany Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 34. France Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 35. U.K. Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 36. Italy Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 37. Netherlands Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 38. Asia Pacific Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 39. Asia Pacific Rosuvastatin Sales Market Share by Country (2021-2032) Figure 40. China Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 41. Japan Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 42. South Korea Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 43. Southeast Asia Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 44. India Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 45. Australia Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 46. South America, Middle East and Africa Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 47. South America, Middle East and Africa Rosuvastatin Sales Market Share by Country (2021-2032) Figure 48. Brazil Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 49. South Africa Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 50. Saudi Arabia Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 51. Turkey Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 52. Argentina Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 53. UAE Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 54. Egypt Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 55. Chile Rosuvastatin Sales and Growth Rate (2021-2032) & (W Tons) Figure 56. Global Rosuvastatin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Rosuvastatin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Rosuvastatin Revenue (2021-2032) & (US$ Million) Figure 59. North America Rosuvastatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Rosuvastatin Revenue (2021-2032) & (US$ Million) Figure 61. Europe Rosuvastatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Rosuvastatin Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Rosuvastatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Rosuvastatin Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Rosuvastatin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Rosuvastatin Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Rosuvastatin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 98.0%
  • Purity 99.0%
  • Other
Applications
  • Tablet
  • Capsule
  • Others
Companies covered
  • Teva Pharmaceutical Industries
  • Shandong Bechem Chemicals
  • Nanjing Frochem Tech
  • Lianyungang Runzhong Pharmaceutical
  • Jingxin Pharm
  • Zhejiang Hisun Pharmaceutical
  • Changzhou Pharmaceutical Factory
  • MSN Laboratories
  • Lunan Pharmaceutical
  • LGM Pharma
  • HEC Pharm
  • CTX Life Sciences
  • Cadila Pharmaceuticals
  • Bal Pharma
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Rosuvastatin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Rosuvastatin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Rosuvastatin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Rosuvastatin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Rosuvastatin Market Dynamics
  1. 2.1 Rosuvastatin Industry Trends
  2. 2.2 Rosuvastatin Industry Drivers
  3. 2.3 Rosuvastatin Industry Opportunities and Challenges
  4. 2.4 Rosuvastatin Industry Restraints
3 Rosuvastatin Market by Manufacturers
  1. 3.1 Global Rosuvastatin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Rosuvastatin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Rosuvastatin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Rosuvastatin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rosuvastatin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Rosuvastatin Manufacturers, Product Type & Application
  7. 3.7 Global Rosuvastatin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rosuvastatin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rosuvastatin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rosuvastatin Tier 1, Tier 2, and Tier 3
4 Rosuvastatin Market by Type
  1. 4.1 Rosuvastatin Type Introduction
  2. 4.1.1 Purity 98.0%
  3. 4.1.2 Purity 99.0%
  4. 4.1.3 Other
  5. 4.2 Global Rosuvastatin Sales by Type
  6. 4.2.1 Global Rosuvastatin Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Rosuvastatin Sales by Type (2021-2032)
  8. 4.2.3 Global Rosuvastatin Sales Market Share by Type (2021-2032)
  9. 4.3 Global Rosuvastatin Revenue by Type
  10. 4.3.1 Global Rosuvastatin Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Rosuvastatin Revenue by Type (2021-2032)
  12. 4.3.3 Global Rosuvastatin Revenue Market Share by Type (2021-2032)
5 Rosuvastatin Market by Application
  1. 5.1 Rosuvastatin Application Introduction
  2. 5.1.1 Tablet
  3. 5.1.2 Capsule
  4. 5.1.3 Others
  5. 5.2 Global Rosuvastatin Sales by Application
  6. 5.2.1 Global Rosuvastatin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rosuvastatin Sales by Application (2021-2032)
  8. 5.2.3 Global Rosuvastatin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Rosuvastatin Revenue by Application
  10. 5.3.1 Global Rosuvastatin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Rosuvastatin Revenue by Application (2021-2032)
  12. 5.3.3 Global Rosuvastatin Revenue Market Share by Application (2021-2032)
6 Global Rosuvastatin Sales by Region
  1. 6.1 Global Rosuvastatin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rosuvastatin Sales by Region (2021-2032)
  3. 6.2.1 Global Rosuvastatin Sales by Region (2021-2026)
  4. 6.2.2 Global Rosuvastatin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Rosuvastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Rosuvastatin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Rosuvastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Rosuvastatin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Rosuvastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Rosuvastatin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Rosuvastatin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Rosuvastatin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Rosuvastatin Revenue by Region
  1. 7.1 Global Rosuvastatin Revenue by Region
  2. 7.1.1 Global Rosuvastatin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Rosuvastatin Revenue by Region (2021-2026)
  4. 7.1.3 Global Rosuvastatin Revenue by Region (2027-2032)
  5. 7.1.4 Global Rosuvastatin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Rosuvastatin Revenue (2021-2032)
  8. 7.2.2 North America Rosuvastatin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Rosuvastatin Revenue (2021-2032)
  11. 7.3.2 Europe Rosuvastatin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Rosuvastatin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Rosuvastatin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Rosuvastatin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Rosuvastatin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Rosuvastatin Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Shandong Bechem Chemicals
  8. 8.2.1 Shandong Bechem Chemicals Company Information
  9. 8.2.2 Shandong Bechem Chemicals Business Overview
  10. 8.2.3 Shandong Bechem Chemicals Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shandong Bechem Chemicals Rosuvastatin Product Portfolio
  12. 8.2.5 Shandong Bechem Chemicals Recent Developments
  13. 8.3 Nanjing Frochem Tech
  14. 8.3.1 Nanjing Frochem Tech Company Information
  15. 8.3.2 Nanjing Frochem Tech Business Overview
  16. 8.3.3 Nanjing Frochem Tech Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nanjing Frochem Tech Rosuvastatin Product Portfolio
  18. 8.3.5 Nanjing Frochem Tech Recent Developments
  19. 8.4 Lianyungang Runzhong Pharmaceutical
  20. 8.4.1 Lianyungang Runzhong Pharmaceutical Company Information
  21. 8.4.2 Lianyungang Runzhong Pharmaceutical Business Overview
  22. 8.4.3 Lianyungang Runzhong Pharmaceutical Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lianyungang Runzhong Pharmaceutical Rosuvastatin Product Portfolio
  24. 8.4.5 Lianyungang Runzhong Pharmaceutical Recent Developments
  25. 8.5 Jingxin Pharm
  26. 8.5.1 Jingxin Pharm Company Information
  27. 8.5.2 Jingxin Pharm Business Overview
  28. 8.5.3 Jingxin Pharm Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jingxin Pharm Rosuvastatin Product Portfolio
  30. 8.5.5 Jingxin Pharm Recent Developments
  31. 8.6 Zhejiang Hisun Pharmaceutical
  32. 8.6.1 Zhejiang Hisun Pharmaceutical Company Information
  33. 8.6.2 Zhejiang Hisun Pharmaceutical Business Overview
  34. 8.6.3 Zhejiang Hisun Pharmaceutical Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zhejiang Hisun Pharmaceutical Rosuvastatin Product Portfolio
  36. 8.6.5 Zhejiang Hisun Pharmaceutical Recent Developments
  37. 8.7 Changzhou Pharmaceutical Factory
  38. 8.7.1 Changzhou Pharmaceutical Factory Company Information
  39. 8.7.2 Changzhou Pharmaceutical Factory Business Overview
  40. 8.7.3 Changzhou Pharmaceutical Factory Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Changzhou Pharmaceutical Factory Rosuvastatin Product Portfolio
  42. 8.7.5 Changzhou Pharmaceutical Factory Recent Developments
  43. 8.8 MSN Laboratories
  44. 8.8.1 MSN Laboratories Company Information
  45. 8.8.2 MSN Laboratories Business Overview
  46. 8.8.3 MSN Laboratories Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MSN Laboratories Rosuvastatin Product Portfolio
  48. 8.8.5 MSN Laboratories Recent Developments
  49. 8.9 Lunan Pharmaceutical
  50. 8.9.1 Lunan Pharmaceutical Company Information
  51. 8.9.2 Lunan Pharmaceutical Business Overview
  52. 8.9.3 Lunan Pharmaceutical Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lunan Pharmaceutical Rosuvastatin Product Portfolio
  54. 8.9.5 Lunan Pharmaceutical Recent Developments
  55. 8.10 LGM Pharma
  56. 8.10.1 LGM Pharma Company Information
  57. 8.10.2 LGM Pharma Business Overview
  58. 8.10.3 LGM Pharma Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 LGM Pharma Rosuvastatin Product Portfolio
  60. 8.10.5 LGM Pharma Recent Developments
  61. 8.11 HEC Pharm
  62. 8.11.1 HEC Pharm Company Information
  63. 8.11.2 HEC Pharm Business Overview
  64. 8.11.3 HEC Pharm Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 HEC Pharm Rosuvastatin Product Portfolio
  66. 8.11.5 HEC Pharm Recent Developments
  67. 8.12 CTX Life Sciences
  68. 8.12.1 CTX Life Sciences Company Information
  69. 8.12.2 CTX Life Sciences Business Overview
  70. 8.12.3 CTX Life Sciences Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CTX Life Sciences Rosuvastatin Product Portfolio
  72. 8.12.5 CTX Life Sciences Recent Developments
  73. 8.13 Cadila Pharmaceuticals
  74. 8.13.1 Cadila Pharmaceuticals Company Information
  75. 8.13.2 Cadila Pharmaceuticals Business Overview
  76. 8.13.3 Cadila Pharmaceuticals Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cadila Pharmaceuticals Rosuvastatin Product Portfolio
  78. 8.13.5 Cadila Pharmaceuticals Recent Developments
  79. 8.14 Bal Pharma
  80. 8.14.1 Bal Pharma Company Information
  81. 8.14.2 Bal Pharma Business Overview
  82. 8.14.3 Bal Pharma Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bal Pharma Rosuvastatin Product Portfolio
  84. 8.14.5 Bal Pharma Recent Developments
  85. 8.15 AstraZeneca
  86. 8.15.1 AstraZeneca Company Information
  87. 8.15.2 AstraZeneca Business Overview
  88. 8.15.3 AstraZeneca Rosuvastatin Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 AstraZeneca Rosuvastatin Product Portfolio
  90. 8.15.5 AstraZeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rosuvastatin Value Chain Analysis
  2. 9.1.1 Rosuvastatin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rosuvastatin Production Mode & Process
  6. 9.2 Rosuvastatin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rosuvastatin Distributors
  9. 9.2.3 Rosuvastatin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst